Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 48 results.
User Information
Export Records
  1. 1.   Sequencing-based functional assays for classification of BRCA2 variants in mouse ESCs
  2. Biswas,Kajal; Mitrophanov,Alex; Sahu,Sounak; Sullivan,Teresa; Southon,Eileen; Nousome,Darryl; Reid, Susan; Narula, Sakshi; Smolen, Julia; Sengupta, Trisha; Riedel-Topper, Maximilian; Kapoor, Medha; Babbar, Anav; Stauffer,Stacey; Cleveland, Linda; Tandon, Mayank; Malys,Tyler; Sharan,Shyam
  3. Cell Reports Methods. 2023, Nov 20; 3(11): 100628.
  1. 2.   Loss of Brca1 and Trp53 in adult mouse mammary ductal epithelium results in development of hormone receptor-positive or hormone receptor-negative tumors, depending on inactivation of Rb family proteins
  2. Szabova,Ludmila; Gordon, Melanie B; Lu, Lucy; Pate, Nathan; Bassel,Laura; Iacovelli, Anthony J; Karim,Baktiar; Homan, Philip J; Householder,Deborah; Guerin,Theresa; Burkett,Sandra; Day,Amanda; Custer Lawrence,Wendi; Ohler,Zoe
  3. Breast Cancer Research : BCR. 2022, Nov 04; 24(1): 75.
  1. 3.   Rare germline variants in PALB2 and BRCA2 in familial and sporadic chordoma
  2. Xia, Bing; Biswas,Kajal; Foo, Tzeh Keong; Torres, Thiago; Riedel-Topper, Maximilian; Southon,Eileen; Kang, Zhihua; Huo, Yanying; Reid,Susan; Stauffer,Stacey; Zhou,Weiyin; Zhu, Bin; Koka, Hela; Yepes, Sally; Brodie, Seth A; Jones,Kristine; Vogt,Aurelie; Zhu,Bin; Cater, Brian; Freedman, Neal D; Hicks,Belynda; Yeager, Meredith; Chanock, Stephen J; Couch, Fergus; Parry, Dilys M; Monteiro, Alvaro N; Goldstein, Alisa M; Carvalho, Marcelo A; Sharan,Shyam; Yang, Xiaohong R
  3. Human Mutation. 2022, Jun 28;
  1. 4.   A phase 1 and pharmacodynamic study of chronically-dosed, single-agent veliparib (ABT-888) in patients with BRCA1- or BRCA2-mutated cancer or platinum-refractory ovarian or triple-negative breast cancer
  2. Manzo, Julia; Puhalla, Shannon; Pahuja, Shalu; Ding, Fei; Lin, Yan; Appleman, Leonard; Tawbi, Hussein; Stoller, Ronald; Lee, James J; Diergaarde, Brenda; Kiesel, Brian F; Yu, Jing; Tan, Antoinette R; Belani, Chandra P; Chew, Helen; Garcia, Agustin A; Morgan, Robert J; Wahner Hendrickson, Andrea E; Visscher, Daniel W; Hurley, Rachel M; Kaufmann, Scott H; Swisher, Elizabeth M; Oesterreich, Steffi; Katz, Tiffany; Ji,Jay; Zhang, Yiping; Parchment, Ralph E; Chen, Alice; Duan, Wenrui; Giranda, Vincent; Shepherd, Stacie P; Ivy, S Percy; Chu, Edward; Beumer, Jan H
  3. Cancer Chemotherapy and Pharmacology. 2022, Apr 18; 89(5): 721-735.
  1. 5.   Germline variants in hereditary breast cancer genes are associated with early age at diagnosis and family history in Guatemalan breast cancer
  2. Ren, Megan; Orozco, Anali; Shao, Kang; Albanez, Anaseidy; Ortiz, Jeremy; Cao, Boyang; Wang, Lusheng; Barreda, Lilian; Alvarez, Christian S.; Garland,Lisa; Wu,Dongjing; Chung,Charles; Wang,Jiahui; Frone, Megan; Ralon, Sergio; Argueta, Victor; Orozco, Roberto; Gharzouzi, Eduardo; Dean, Michael
  3. Breast cancer research and treatment. 2021, Jul 1;
  1. 6.   Epidemiological and ES cell-based Functional Evaluation of BRCA2 Variants Identified in Families with Breast Cancer
  2. O'Sullivan,Theresa; Thirthagiri, Eswary; Chong, Chan-Eng; Stauffer,Stacey; Reid,Susan; Southon,Eileen; Hassan, Tiara; Ravichandran, Aravind; Wijaya, Eldarina; Lim, Joanna; Taib, Nur Aishah Mohd; Fadzli, Farhana; Yip, Cheng Har; Hartman, Mikael; Li, Jingmei; van Dam, Rob M; North, Susan L; Das, Ranabir; Easton, Douglas F; Biswas,Kajal; Teo, Soo-Hwang; Sharan,Shyam
  3. Human Mutation. 2021, Feb; 42(2): 200-212.
  1. 7.   Exploring role of 5hmC as potential marker of chemoresistance
  2. Kharat,Suhas; Sharan,Shyam
  3. MOLECULAR & CELLULAR ONCOLOGY. 2020, Oct 22; 7(6): 1827904.
  1. 8.   Functional evaluation of five BRCA2 unclassified variants identified in a Sri Lankan cohort with inherited cancer syndromes using a mouse embryonic stem cell-based assay
  2. Sirisena, Nirmala; Biswas,Kajal; Sullivan,Teresa; Stauffer,Stacey; Cleveland, Linda; Southon,Eileen; Dissanayake, Vajira H W; Sharan,Shyam
  3. Breast cancer research : BCR. 2020, May 11; 22(1): 43.
  1. 9.   BRCA1 promoter hypermethylation in human placenta: A hidden link with ß-hCG expression
  2. Nadhan, Revathy; Vaman, Jayashree V; Sengodan,Satheesh; Hemalatha, Sreelatha K; Nirmala, C; Sadasivan, Santha; Aysha, P V; Yesodharan, Sreelekha; Krishnapriya, R S; Amritha Krishna, B V; P S, Sreevidya; Rajan, Arathi; Rajan Latha, Neetha; Varghese, Geetu Rose; Thankappan, Ratheeshkumar; Achyutuni, Sarada; Jithin, Dev S U; Anil Kumar, T V; Srinivas, Priya
  3. Carcinogenesis. 2020, MAY; 41(5): 611-624.
  1. 10.   RAD52 S346X Variant Reduces Breast Cancer Risk in BRCA2 Mutation Carriers
  2. Biswas,Kajal; Sharan,Shyam
  3. Molecular oncology. 2020, Apr 07;
  1. 11.   Sensitivity of mesothelioma cells to PARP inhibitors is not dependent on BAP1 but is enhanced by temozolomide in cells with high-Schlafen 11and low-MGMT expression
  2. Rathkey, Daniel; Khanal, Manakamana; Murai, Junko; Zhang, Jingli; Sengupta, Manjistha; Jiang, Qun; Morrow, Betsy; Evans,Christine; Chari,Raj; Fetsch, Patricia; Chung, Hye-Jung; Xi, Liqiang; Roth, Mark; Filie, Armando; Raffeld, Mark; Thomas, Anish; Pommier, Yves; Hassan, Raffit
  3. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer. 2020, Jan 28; pii: S1556-0864(20)30035-6.
  1. 12.   Mouse Ovarian Cancer Models Recapitulate the Human Tumor Microenvironment and Patient Response to Treatment
  2. Maniati, Eleni; Berlato, Chiara; Gopinathan, Ganga; Heath, Owen; Kotantaki, Panoraia; Lakhani, Anissa; McDermott, Jacqueline; Pegrum, Colin; Delaine-Smith, Robin M; Pearce, Oliver M T; Hirani, Priyanka; Joy, Joash D; Szabova,Ludmila; Perets, Ruth; Sansom, Owen J; Drapkin, Ronny; Bailey, Peter; Balkwill, Frances R
  3. Cell reports. 2020, Jan 14; 30(2): 525-540.e7.
  1. 13.   ß-hCG induced mutant BRCA1 ignites drug resistance in susceptible breast tissue
  2. Sengodan,Satheesh; Hemalatha, Sreelatha K; Nadhan, Revathy; Somanathan, Thara; Mathew, Arun Peter; Chil, Arkadiusz; Kopczynski, Janusz; Nair, Rakesh Sathish; Kumar, Jerald Mahesh; Srinivas, Priya
  3. Carcinogenesis. 2019, Nov; 40(11): 1415-1426.
  1. 14.   A Recurrent BRCA2 Mutation Explains the Majority of Hereditary Breast and Ovarian Cancer Syndrome Cases in Puerto Rico
  2. Diaz-Zabala, Hector J; Ortiz, Ana P; Garland, Lisa; Jones, Kristine; Perez, Cynthia M; Mora, Edna; Arroyo, Nelly; Oleksyk, Taras K; Echenique, Miguel; Matta, Jaime L; Dean, Michael; Dutil, Julie
  3. Cancers. 2018, Nov 02; 10(11): pii: E419.
  1. 15.   Survival of BRCA2-Deficient Cells Is Promoted by GIPC3, a Novel Genetic Interactor of BRCA2
  2. Ding, Xia; Philip, Subha; Martin, Betty; Pang, Yan; Burkett, Sandra; Swing, Debbie; Pamala, Chinmayi; Ritt, Daniel A; Zhou, Ming; Morrison, Deborah; Ji, Xinhua; Sharan, Shyam
  3. Genetics. 2017, Dec; 207(4): 1335-1345.
  1. 16.   Prevalence and spectrum of germline rare variants in BRCA1/2 and PALB2 among breast cancer cases in Sarawak, Malaysia
  2. Yang, Xiaohong R; Devi, Beena C R; Sung, Hyuna; Guida, Jennifer; Mucaki, Eliseos J; Xiao, Yanzi; Best, Ana; Garland, Lisa; Xie, Yi; Hu, Nan; Rodriguez-Herrera, Maria; Wang, Chaoyu; Jones, Kristine; Luo, Wen; Hicks, Belynda; Tang, Tieng Swee; Moitra, Karobi; Rogan, Peter K; Dean, Michael
  3. Breast Cancer Research and Treatment. 2017, Oct; 165: 687-697.
  1. 17.   RADX Promotes Genome Stability and Modulates Chemosensitivity by Regulating RAD51 at Replication Forks.
  2. Dungrawala, Huzefa; Bhat, Kamakoti P; Le Meur, Rémy; Chazin, Walter J; Ding, Xia; Sharan, Shyam; Wessel, Sarah R; Sathe, Aditya A; Zhao, Runxiang; Cortez, David
  3. Molecular cell. 2017, Aug 3; 67(3): 374-+.
  1. 18.   Parent-Metabolite Pharmacokinetic Modeling and Pharmacodynamics of Veliparib (ABT-888), a PARP Inhibitor, in Patients With BRCA 1/2-Mutated Cancer or PARP-Sensitive Tumor Types
  2. Niu, Jing; Scheuerell, Christie; Mehrotra, Shailly; Karan, Sharon; Puhalla, Shannon; Kiesel, Brian F; Ji, Jay; Chu, Edward; Gopalakrishnan, Mathangi; Ivaturi, Vijay; Gobburu, Jogarao; Beumer, Jan H
  3. Journal of clinical pharmacology. 2017, Aug; 57(8): 977-987.
  1. 19.   Next Generation Sequencing Reveals High Prevalence of BRCA1 and BRCA2 Variants of Unknown Significance in Early-Onset Breast Cancer in African American Women.
  2. Ricks-Santi, Luisel; McDonald, J Tyson; Gold, Bert; Dean, Michael; Thompson, Nicole; Abbas, Muneer; Wilson, Bradford; Kanaan, Yasmine; Naab, Tammey J; Dunston, Georgia
  3. Ethnicity & disease. 2017, Apr 20; 27(2): 169-178.
  1. 20.   Plumbagin, a naphthaquinone derivative induces apoptosis in BRCA 1/2 defective castrate resistant prostate cancer cells as well as prostate cancer stem-like cells
  2. Reshma, R. S.; Sreelatha, K. H.; Somasundaram, V.; Satheesh Kumar, S.; Nadhan, R.; Nair, R. S.; Srinivas, P.
  3. Pharmacological Research. 2016, Mar; 105: 134-45.
  1. 21.   Advances in using PARP inhibitors to treat cancer
  2. Kummar, S.; Chen, A.; Parchment, R. E.; Kinders, R. J.; Ji, J.; Tomaszewski, J. E.; Doroshow, J. H.
  3. Bmc Medicine. 2012, Mar; 10
  1. 22.   CHEK2 genomic and proteomic analyses reveal genetic inactivation or endogenous activation across the 60 cell lines of the US National Cancer Institute
  2. Zoppoli, G.; Solier, S.; Reinhold, W. C.; Liu, H.; Connelly, J. W.; Monks, A.; Shoemaker, R. H.; Abaan, O. D.; Davis, S. R.; Meltzer, P. S.; Doroshow, J. H.; Pommier, Y.
  3. Oncogene. 2012, Jan; 31(4): 403-418.
  1. 23.   Yin Yang 1 positively regulates BRCA1 and inhibits mammary cancer formation
  2. Lee, M. H.; Lahusen, T.; Wang, R. H.; Xiao, C.; Xu, X.; Hwang, Y. S.; He, W. W.; Shi, Y.; Deng, C. X.
  3. Oncogene. 2012, Jan; 31(1): 116-127.
  1. 24.   X-ray structures of checkpoint kinase 2 in complex with inhibitors that target its gatekeeper-dependent hydrophobic pocket
  2. Lountos, G. T.; Jobson, A. G.; Tropea, J. E.; Self, C. R.; Zhang, G. T.; Pommier, Y.; Shoemaker, R. H.; Waugh, D. S.
  3. Febs Letters. 2011, Oct; 585(20): 3245-3249.
  1. 25.   A comprehensive functional characterization of BRCA2 variants associated with Fanconi anemia using mouse ES cell-based assay
  2. Biswas, K.; Das, R.; Alter, B. P.; Kuznetsov, S. G.; Stauffer, S.; North, S. L.; Burkett, S.; Brody, L. C.; Meyer, S.; Byrd, R. A.; Sharan, S. K.
  3. Blood. 2011, Sep; 118(9): 2430-2442.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel